Cataracts are a leading cause of blindness worldwide and are considered a priority disease by the World Health Organization.
Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results